KIT and melanoma: The aim of this study was to evaluate the efficacy of nilotinib in advanced KIT-mutated melanoma, to explore the particularities of KIT mutation and copy number amplification and benefit from treatment, and to assess the value of droplet digital PCR (ddPCR) for the liquid biopsy of melanomas with uncommon KIT mutations and complex aberrations.